Harvard Apparatus Regenerative Technology HRGN
OTC HRGN
$2.19 -0.01 (-0.45%)
At close: Oct 2, 2026 · 4:00 PM EDT

Harvard Apparatus Regenerative Technology (HRGN) Current Deferred Revenue (2025 - 2026)

Updated

Harvard Apparatus Regenerative Technology (HRGN) recorded Current Deferred Revenue of $603,000 in Q2 2026, up 304.7% from $149,000 a year earlier and up 77.4% from the prior quarter.

Analysis

Harvard Apparatus Regenerative Technology (HRGN) Current Deferred Revenue (2025 - 2026) Analysis & Trends

At the end of FY2025, Harvard Apparatus Regenerative Technology reported Current Deferred Revenue of $252,000.

  • Per Business Quant, the preceding three quarters came in at $340,000 (Q1 2026), $252,000 (Q4 2025) and $128,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Harvard Apparatus Regenerative Technology 38.50 Mn 35.01 Mn 23,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 603,000.00
Mar 31, 2026 340,000.00
Dec 31, 2025 252,000.00
Sep 30, 2025 128,000.00
Jun 30, 2025 149,000.00
Mar 31, 2025 299,000.00
API Access

Harvard Apparatus Regenerative Technology Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=HRGN&period=max&api_key=YOUR_API_KEY